Pillsbury Winthrop Shaw Pittman LLP advised Sentynl Therapeutics on the deal. Sentynl Therapeutics, a USA-based specialty pharma company owned by the India’s Zydus Group, announced the agreement...
This content is for Standard 1 Year members only. LoginJoin Now